Drug General Information (ID: DDI37W2CQS)
  Drug Name Nitazoxanide Drug Info Glipizide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiparasitic Agents Antidiabetic Agents
  Structure

 Mechanism of Nitazoxanide-Glipizide Interaction (Severity Level: Moderate)
     Competitive binding of plasma proteins Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Nitazoxanide Glipizide
      Mechanism Competition for plasma protein binding sites Competition for plasma protein binding sites
      Key Mechanism Factor 1
Factor Name Plasma protein binding
Factor Description Plasma protein binding refers to the degree of binding of a drug to proteins in the blood, and the lower the degree of binding, the more efficiently the drug can cross cell membranes or diffuse. Plasma protein binding alters the distribution and therapeutic characteristics of the drugs.
      Mechanism Description
  • Increased plasma concentration of Glipizide and Nitazoxanide due to competitive binding of plasma proteins

Recommended Action
      Management Caution is advised when other highly protein-bound drugs are used with nitazoxanide, particularly those with a narrow therapeutic index. Patients should be monitored more closely following the addition or withdrawal of nitazoxanide. When performing therapeutic drug monitoring, total plasma concentrations should be interpreted cautiously due to the possibility of increased free (unbound) drug.

References
1 Product Information. Alinia (nitazoxanide). Romark Laboratories L.C., Tampa, FL.